The Be COn Building excellence and Continuity in Onco-care brand, founded in 2015 (Netherlands), from 293 sister brands and 4958 competing brands. Be COn Building excellence and Continuity in Onco-care is owned by TEVA PHARMACEUTICALS INDUSTRIES LIMITED, listed on the stock exchange of New York Be COn Building excellence and Continuity in Onco-care belongs to the Drug Manufacturers business sector.
Share price and profitability of the share TEVA PHARMACEUTICALS INDUSTRIES LIMITED (Be COn Building excellence and Continuity in Onco-care)
Buy TEVA PHARMACEUTICALS INDUSTRIES LIMITED share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
TEVA PHARMACEUTICALS INDUSTRIES LIMITED
(Be COn Building excellence and Continuity in Onco-care)
over 5 years*
USD 11.07
Stock market history TEVA PHARMACEUTICALS INDUSTRIES LIMITED (Be COn Building excellence and Continuity in Onco-care)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
